Latest stock market podcasts

From the helm: CSL's David Lamont on the biotech giant's bright future

Bell Direct
February 20, 2020

In the latest instalment of Bell Direct’s From the helm series, Jess has a chat with CSL’s CFO David Lamont. 

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 24 September

Bell Direct
September 24, 2020

Morning Bell 23 September

Bell Direct
September 23, 2020

Morning bell 22 September

Bell Direct
September 22, 2020

Morning Bell 21 September

Bell Direct
September 21, 2020

Weekly Wrap 18 September

Bell Direct
September 18, 2020

Morning Bell 18 September

Bell Direct
September 18, 2020

Morning Bell 17 September

Bell Direct
September 17, 2020

Morning Bell 16 September

Bell Direct
September 16, 2020

Morning Bell 15 September

Bell Direct
September 15, 2020

Morning Bell 14 September

Bell Direct
September 14, 2020

Weekly Wrap 11 September

Bell Direct
September 11, 2020